Yes, I think that the collaboration between industry and clinician and clinical researcher is unavoidable because, you know, we need to work with the industry. They own the new molecules. They can develop a new drug. And if we want to offer very early a new drugs to the patient, we need it to be part of the development of the drug. In the meantime, industry needs us to have some hint on what is really relevant for patient...
Yes, I think that the collaboration between industry and clinician and clinical researcher is unavoidable because, you know, we need to work with the industry. They own the new molecules. They can develop a new drug. And if we want to offer very early a new drugs to the patient, we need it to be part of the development of the drug. In the meantime, industry needs us to have some hint on what is really relevant for patient. Just to focus the research in the field that are absolutely important for obviously all the society and all the patients. So I think it’s a bi-directional collaboration and we should all work to keep it in a very critical environment with the purpose of offering the best innovation to our patients.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
